The Safety and Efficacy of Initiating Insulin Therapy in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Previous Oral Antidiabetic Drugs

Qing Su

2011-01-01

Abstract:Objective To evaluate the safety and efficacy of initiating insulin therapy in Chinese patients with type 2 diabetes mellitus(T2DM) inadequately controlled with previous oral antidiabetic drugs(OADs).Methods Insulin therapy was initiated and had been administrated for 16 weeks in Chinese patients with T2DM inadequately controlled with previous OADs.Safety and efficacy data were collected at baseline and at the end of 16 weeks.Results Totally 4847 T2DM patients were enrolled in the study with 2327 females(48.0%).There were 4364(90.04%) patients who completed both baseline and end-study visits.Enrolled patients had a mean age of 59.7±12.2 years and T2DM duration of 7.94±6.13 years.Prior to the initiation of insulin,mean glycosylated hemoglobin A1c(HbA_1c) was 9.65±2.12%.The proportion of patients using premix human insulin was the highest(38.1%),followed by premix insulin analogue(31.3%).The lowest incidence of major hypoglycaemia(0.02 events/person/ year) and nocturnal hypoglycaemia(0.27 events/person year) was observed in patients using basal insulin and basal-bolus insulin analogue respectively.The mean HbA_1c was reduced by 2.3%(P0.001) after 16 weeks of insulin therapy.The reduction of HbA_1c was the highest in patients with basal-bolus insulin analogue(3.02±1.94%%),followed by premix insulin analogue(2.61±1.97%%).The percentage of patients reaching the target HbA_1c7.0%was 43.2%.The average fasting blood glucose and postprandial blood glucose were reduced by 3.21 mmol/L and 5.21 mmol/L(P0.001),respectively, with the highest decrement in patients using basal-bolus insulin analogue.Conclusion The overall glycemic control is significantly improved after 16 weeks of insulin therapy.The patients with basal insulin treatment have the lowest safety concern.The most considerable improvement of HbA_1c,fasting and postprandial blood glucose is observed in patients using basal-bolus insulin.Premix insulin is the most commonly used for initiating insulin therapy in Chinese T2DM patients,and its safety and efficacy are between the above two insulin therapies.The percentages of patients reaching the target HbAiC7%and≤6.5%without hypoglycaemia in premix insulin analogue treatment group are higher than in other commonly used insulin therapies.